Size | Price | Stock | Qty |
---|---|---|---|
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
Other Sizes |
|
MRS1754 (MRS-1754; MRS 1754) is a novel, selective and potent A2B antagonist 2B antagonist with anticancer activity. It prevents bladder urothelial carcinoma cells from proliferating and migrating by adjusting the MAPK (mitogen-activated protein kinase) pathway,.
Targets |
A2 Adenosine Receptor
|
---|---|
ln Vitro |
MRS 1754 is the most effective displacer of [3H]MRS 1754 binding. Relative to human A2B receptors expressed in HEK-293 cell membranes, the displacement of [3H]MRS 1754 binding has a Ki value of 1.45±0.21 nM[1].
|
References | |
Additional Infomation |
N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide is an oxopurine.
|
Molecular Formula |
C26H26N6O4
|
---|---|
Molecular Weight |
486.532
|
Exact Mass |
486.202
|
Elemental Analysis |
C, 64.19; H, 5.39; N, 17.27; O, 13.15
|
CAS # |
264622-58-4
|
PubChem CID |
6603931
|
Appearance |
White to off-white solid powder
|
Density |
1.38g/cm3
|
LogP |
3.335
|
Hydrogen Bond Donor Count |
2
|
Hydrogen Bond Acceptor Count |
6
|
Rotatable Bond Count |
9
|
Heavy Atom Count |
36
|
Complexity |
843
|
Defined Atom Stereocenter Count |
0
|
SMILES |
O=C1N(C(C2=C(N=C(C3C=CC(=CC=3)OCC(N([H])C3C=CC(C#N)=CC=3)=O)N2[H])N1CCC)=O)CCC
|
InChi Key |
AJBBEYXFRYFVNM-UHFFFAOYSA-N
|
InChi Code |
InChI=1S/C26H26N6O4/c1-3-13-31-24-22(25(34)32(14-4-2)26(31)35)29-23(30-24)18-7-11-20(12-8-18)36-16-21(33)28-19-9-5-17(15-27)6-10-19/h5-12H,3-4,13-14,16H2,1-2H3,(H,28,33)(H,29,30)
|
Chemical Name |
N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide
|
Synonyms |
MRS1754; MRS-1754; MRS 1754
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO: ~15 mg/mL (~30.8 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 1.5 mg/mL (3.08 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 15.0 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 1.5 mg/mL (3.08 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 15.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: 1.5 mg/mL (3.08 mM) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.0554 mL | 10.2769 mL | 20.5537 mL | |
5 mM | 0.4111 mL | 2.0554 mL | 4.1107 mL | |
10 mM | 0.2055 mL | 1.0277 mL | 2.0554 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.